Shandong Nuohekang Pharmaceutical

Shandong Nuohekang Pharmaceutical is a Chinese pharmaceutical company headquartered in Jinan, Shandong, specializing in the research, development, and production of high-end active pharmaceutical ingredients (APIs) and chemical intermediates. Founded in 2015, the company has established a robust presence in the fields of diabetes management and cardiovascular health, particularly focusing on anticoagulants and DPP-4 inhibitors. Its manufacturing facilities are designed to meet international GMP standards, enabling the supply of high-quality chemical products to global markets. Nuohekang integrates advanced chemical synthesis technologies with large-scale production capabilities to support both generic drug development and custom manufacturing services. The company is recognized as a high-tech enterprise, emphasizing continuous innovation in process chemistry and pharmaceutical engineering.